Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infection

BACKGROUND: This study aimed to consider the main risk factors related to adverse clinical outcomes in MS patients with COVID-19. METHODS: Using the electronic health records systems, this is a cross-sectional study of two years of hospital admissions in terms of COVID-19 in Iran from March 2019 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Maghbooli, Zhila, Hosseinpour, Hesham, Fattahi, Mohammad Reza, Varzandi, Tarlan, Hamtaeigashi, Sara, Mohammad-nabi, Sara, Aghababaei, Yasaman, Sahraian, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306262/
https://www.ncbi.nlm.nih.gov/pubmed/35933755
http://dx.doi.org/10.1016/j.msard.2022.104067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306262/
https://www.ncbi.nlm.nih.gov/pubmed/35933755
http://dx.doi.org/10.1016/j.msard.2022.104067

Ejemplares similares